|
| Exchange Received Time 01/12/2018 13:01:14 Exchange Disseminated Time 01/12/2018 13:01:22 Time Taken 00:00:08 | Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and our announcement dated 28 November 2018, this is for the information of all concerned that Merck KGaA, Germany has announced today that closing under the share purchase and asset sale agreement entered into by it with The Procter & Gamble Company, amongst others, has taken place. Accordingly, closing under the India Sale and Purchase Agreement, dated April 19, 2018, by and among, Merck Internationale Beteiligungen GmbH, Chemitra Gesellschaft mit beschränkter Haftung, Emedia Export Company mit beschränkter Haftung, Merck KGaA and Procter & Gamble Overseas India B.V, has also taken place. Copy of a press release issued by Merck KGaA in this respect is attached herewith. Further to our announcements dated June 13, 2018 and June 21, 2018, (i) the business transfer agreement dated June 21, 2018 amongst the Company and Merck Life Science Private Limited ('MLSPL') for the transfer of the Company''s biopharma ('BP'), performance materials ('PM') and life science ('LS') businesses to MLSPL and/or its affiliates; and (ii) pursuant to and in connection therewith, an agreement with MLSPL, Merck Specialities Private Limited ('MSPL') and Merck Performance Materials Private Limited ('MPMPL') for the direct transfer of the BP and PM businesses to MSPL and MPMPL respectively, in accordance with the terms and conditions of such agreements, have also closed.
This is for your information and records.
|
|
|